Drugs interactions for Levulan Kerastick®
- 0 Major drug interactions
- 27 Moderate drug interactions (including ingredients like Articaine, Benzocaine, Benzyl alcohol)
- 2 Minor drug interactions (including ingredients like Porfimer sodium, Verteporfin)
29 interactions for Levulan Kerastick®The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Articaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Benzocaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Benzyl alcohol.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Bupivacaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Butamben.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Capsaicin.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Chloroprocaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Cinchocaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Cocaine.The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aminolevulinic acid.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Diphenhydramine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Dyclonine.The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminolevulinic acid.The risk or severity of immunosuppression can be increased when Aminolevulinic acid is combined with Etrasimod.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Lidocaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Meloxicam.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Mepivacaine.The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Aminolevulinic acid.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Oxybuprocaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Phenol.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Pramocaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Prilocaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Procaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Proparacaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Ropivacaine.The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Tetracaine.The risk or severity of adverse effects can be increased when Tretinoin is combined with Aminolevulinic acid.Aminolevulinic acid may increase the photosensitizing activities of Porfimer sodium.Aminolevulinic acid may increase the photosensitizing activities of Verteporfin.
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and Levulan Kerastick®.
Articaine
Benzocaine
Benzyl alcohol
Bupivacaine
Butamben
Capsaicin
Chloroprocaine
Cinchocaine
Cocaine
Darbepoetin alfa
Diphenhydramine
Dyclonine
Erythropoietin
Etrasimod
Lidocaine
Meloxicam
Mepivacaine
Methoxy polyethylene glycol-epoetin beta
Oxybuprocaine
Phenol
Pramocaine
Prilocaine
Procaine
Proparacaine
Ropivacaine
Tetracaine
Tretinoin
Porfimer sodium
Verteporfin